Mike Druhan on the competitive advantages of MedX’s skin cancer diagnosis technology
“We have launched a new product called DermSecureTM…We can take a picture on the top of the skin of a melanoma or a potential melanoma or any type of skin cancer. We can look two millimeters below the skin. It is best image capture system in the world. We have coupled that on the top of a platform that allows us to be infinitely scalable on a global basis. That’s why you are starting to see the deals we are doing because of the acceptance and adoption of this technology.” States Mike Druhan, Vice President of Corporate Development at MedX Health Corp. (TSXV: MDX), in an interview with InvestorIntel’s Tracy Weslosky.
Tracy Weslosky: MedX Health is one of the most exciting companies currently on the stock market in Canada. Can you tell the InvestorIntel audience why you are so competitive?
Mike Druhan: We are pretty excited right now. We have launched a new product called DermSecureTM and this is a platform that allows us to take our technology, which is our image capture technology, which is only one like it in the globe. We can take a picture on the top of the skin of a melanoma or a potential melanoma or any type of skin cancer. We can look two millimeters below the skin. It is best image capture system in the world. We have coupled that on the top of a platform that allows us to be infinitely scalable on a global basis. That’s why you are starting to see the deals we are doing because of the acceptance and adoption of this technology. It is very exciting time for MedX.
Tracy Weslosky: The keyword I heard here is, you are now scalable. Is that correct?
Mike Druhan: You have got it.
Tracy Weslosky: So, we are scalable and that means revenue. Does it not Mike?
Mike Druhan: Yes. Revenue is the big function. We have converted the technology with the platform to a SAAS model. So that means there is a lot of recurring revenue in our upcoming future and because we can quickly adapt large scale projects…to access the complete interview, click here
Disclaimer: MedX Health Corp. is an advertorial member of InvestorIntel Corp.
Raj Shah has been a member of the InvestorIntel.com team for the last nearly 9 years. Recruited from Merrill Lynch, he has over 13 years’ ... <Read more about Raj Shah>
